S0013 was terminated at the end of 2025 and replaced by J0013, which is behind a lot of this year's denials. Here is the current code set, why how you acquire the drug decides which half of it applies to you, and where payers disagree with each other.
10 min read
The enrollment form is the smallest part of the Spravato REMS. A prescriber on site, a pulse oximeter, a monitoring form within seven days of every dose, and at least two hours per patient per session. Here is what the program requires and what it does to your capacity.
10 min read
The manufacturer will not promise a reimbursement level for its own drug, and neither should anyone else. What determines your rate, how to find it, exactly who qualifies for the withMe savings program, and why most denials are administrative rather than clinical.
8 min read
IV ketamine is off-label and cash-pay. Spravato is FDA-approved and insurance-covered. That one difference changes the patient, the compliance limits, the keywords worth buying and where referrals come from. A channel-by-channel breakdown with US search data.
16 min read
Spravato clinic marketing works differently because esketamine is a REMS-controlled medication with restricted advertising, so steady patient flow comes from referrals, the Find a Center listing, local search, and education. Build that compliant base before you spend on paid ads.
6 min read
